Daxor Corporation Fundamental Analysis (NASDAQ: DXR)
Daxor Corporation Fundamental Analysis (NASDAQ: DXR)
Daxor Corporation (NASDAQ: DXR) shows moderate financial fundamentals with a PE ratio of 9.16, profit margin of 40.22%, and ROE of 12.75%. The company generates $0.0B in annual revenue with weak year-over-year growth of -76.37%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -29.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze DXR's fundamental strength across five key dimensions:
Efficiency Score
ExcellentDXR demonstrates superior asset utilization.
Valuation Score
ExcellentDXR trades at attractive valuation levels.
Growth Score
ModerateDXR shows steady but slowing expansion.
Financial Health Score
ModerateDXR shows balanced financial health with some risks.
Profitability Score
WeakDXR struggles to sustain strong margins.
Key Financial Metrics
Is DXR Expensive or Cheap?
P/E Ratio
DXR trades at 9.16 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, DXR's PEG of 0.04 indicates potential undervaluation.
Price to Book
The market values Daxor Corporation at 1.08 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 10.56 times EBITDA. This signals the market has high growth expectations.
How Well Does DXR Make Money?
Net Profit Margin
For every $100 in sales, Daxor Corporation keeps $40.22 as profit after all expenses.
Operating Margin
Core operations generate 40.24 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $12.75 in profit for every $100 of shareholder equity.
ROA
Daxor Corporation generates $12.01 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Daxor Corporation generates limited operating cash flow of $-3.29M, signaling weaker underlying cash strength.
Free Cash Flow
Daxor Corporation generates weak or negative free cash flow of $-3.29M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.56 in free cash annually.
FCF Yield
DXR converts -4.30% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
9.16
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.04
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.08
vs 25 benchmark
P/S Ratio
Price to sales ratio
424.86
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.13
vs 25 benchmark
ROA
Return on assets percentage
0.12
vs 25 benchmark
ROCE
Return on capital employed
0.12
vs 25 benchmark
How DXR Stacks Against Its Sector Peers
| Metric | DXR Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 9.16 | 31.29 | Better (Cheaper) |
| ROE | 12.75% | 521.00% | Weak |
| Net Margin | 4021.89% | 21470.00% | Weak |
| Debt/Equity | 0.00 | 0.53 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 5.61 | Weak Liquidity |
| ROA | 12.01% | -203.00% (disorted) | Strong |
DXR outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROA, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Daxor Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
114.16%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
524.51%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
80.50%
Industry Style: Defensive, Growth, Innovation
High Growth